Group B Streptococcus Evades Host Immunity by Degrading Hyaluronan

Area of Science:

• Immunology
• Microbiology
• Biochemistry

Background:

• Tissue injury triggers hyaluronan (HA) cleavage into fragments that activate Toll-like receptors (TLRs) and cause inflammation.
• Pathogenic bacteria, like group B Streptococcus (GBS), use hyaluronidases for invasion, but their role in immune evasion is unclear.

Purpose of the Study:

• To investigate how bacterial hyaluronidases affect immune detection of hyaluronan.
• To determine the potential of bacterial hyaluronidase activity and HA disaccharides as therapeutic strategies for inflammatory diseases.

Main Methods:

• Analyzing the degradation products of HA by bacterial hyaluronidases from GBS and other Gram-positive pathogens.
• Assessing the impact of HA disaccharides on TLR2/4 signaling pathways.
• Evaluating the efficacy of GBS hyaluronidase and HA disaccharides in an acute lung injury model.

Main Results:

• Bacterial hyaluronidases degrade pro-inflammatory HA fragments into non-inflammatory disaccharides.
• HA disaccharides inhibit TLR2/4 signaling induced by both HA fragments and other ligands like lipopolysaccharide.
• Treatment with GBS hyaluronidase or HA disaccharides reduced lung inflammation and pro-inflammatory cytokine levels in an acute lung injury model.

Conclusions:

• Bacterial pathogens degrade host-derived pro-inflammatory HA fragments to disaccharides, enabling immune evasion.
• HA disaccharides represent a potential therapeutic target for managing inflammatory diseases by blocking TLR signaling.